New Rufomycins from Streptomyces atratus MJM3502 Expand Anti- Mycobacterium tuberculosis Structure-Activity Relationships

被引：4

作者：

Zhou, Bin ^{[1
,2
,3
,4
]}

Shetye, Gauri ^{[3
]}

Wolf, Nina M. ^{[3
]}

Chen, Shao-Nong ^{[1
,2
,3
]}

Qader, Mallique ^{[3
]}

Ray, G. Joseph ^{[1
,2
,3
]}

Lankin, David C. ^{[1
,2
,3
]}

Cho, Sanghyun ^{[3
]}

Cheng, Jinhua ^{[5
]}

Suh, Joo-Won ^{[5
]}

Franzblau, Scott G. ^{[1
,2
,3
]}

McAlpine, James B. ^{[1
,2
,3
]}

Pauli, Guido F. ^{[1
,2
,3
]}

机构：

[1] Univ Illinois, Pharmacognosy Inst, Coll Pharm, Chicago, IL 60612 USA

[2] Univ Illinois, Dept Pharmaceut Sci Coll Pharm, Chicago, IL 60612 USA

[3] Univ Illinois, Inst TB Res, Coll Pharm, Chicago, IL 60612 USA

[4] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China

[5] Myongji Univ, Myongji Bioefficacy Res Ctr, Yongin 17058, Gyeonggi Do, South Korea

来源：

ORGANIC LETTERS | 2022年

基金：

美国国家卫生研究院;

关键词：

ABSOLUTE-CONFIGURATION;

D O I：

10.1021/acs.orglett.2c02493

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Four new rufomycins, compounds 1-4, named rufomycins 56, 57, 58, and 61, respectively, exhibiting new skeletal features, were obtained from Streptomyces atratus strain MJM3502 and were fully characterized. Compounds 1 and 2 possess a 4imidazolidinone ring not previously encountered in this family of cyclopeptides, thereby resulting in a [5,17] bicyclic framework. The in vitro anti -Mycobacterium tuberculosis potency of compounds 3 and 4 is remarkable, with minimum inhibitory concentration values of 8.5 and 130 nM, respectively.

引用

页码：7265 / 7270

页数：6

共 50 条

[1] Antimycobacterial Rufomycin Analogues from Streptomyces atratus Strain MJM3502
Zhou, Bin
Shetye, Gauri
Yu, Yang
Santarsiero, Bernard D.
Klein, Larry L.
Abad-Zapatero, Cele
Wolf, Nina M.
Cheng, Jinhua
Jin, Yingyu
Lee, Hanki
Suh, Joo-Won
Lee, Hyun
Bisson, Jonathan
McAlpine, James B.
Chen, Shao-Nong
Cho, Sang-Hyun
Franzblau, Scott G.
Pauli, Guido F.
JOURNAL OF NATURAL PRODUCTS, 2020, 83 (03): : 657 - 667
[2] Structure-activity relationships of macrolides against Mycobacterium tuberculosis
Zhu, Zhaohai J.
Krasnykh, Olga
Pan, Dahua
Petukhova, Valentina
Yu, Gengli
Liu, Yinghui
Liu, Huiwen
Hong, Saweon
Wang, Yuehong
Wan, Baojie
Liang, Wenzhong
Franzblau, Scott G.
TUBERCULOSIS, 2008, 88 : S49 - S63
[3] Study of the structure-activity relationships for the pyrazinamidase (PncA) from Mycobacterium tuberculosis
Lemaitre, N
Callebaut, I
Frenois, F
Jarlier, V
Sougakoff, W
BIOCHEMICAL JOURNAL, 2001, 353 : 453 - 458
[4] Synthesis and structure-activity relationships for a new class of tetrahydronaphthalene amide inhibitors of Mycobacterium tuberculosis
Sutherland, Hamish S. S.
Lu, Guo-Liang
Tong, Amy S. T. G.
Conole, Daniel M.
Franzblau, Scott G. U.
Upton, Anna B.
Lotlikar, Manisha U. D.
Cooper, Christopher B. J.
Palmer, Brian D. A.
Choi, Peter J.
Denny, William A.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 229
[5] Structure-Activity Relationships of Pyrrole Hydrazones as New Anti-Tuberculosis Agents
Lessigiarska, Iglika
Pajeva, Ilza
Prodanova, Penka
Georgieva, Maya
Bijev, Atanas
MEDICINAL CHEMISTRY, 2012, 8 (03) : 462 - 473
[6] Synthesis and structure-activity relationships for tetrahydroisoquinoline-based inhibitors of Mycobacterium tuberculosis
Lu, Guo-Liang
Tong, Amy S. T.
Conole, Daniel
Sutherland, Hamish S.
Choi, Peter J.
Franzblau, Scott G.
Upton, Anna M.
Lotlikar, Manisha U.
Cooper, Christopher B.
Denny, William A.
Palmer, Brian D.
BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (22)
[7] Quantitative structure-activity relationships of cobalt pyrophosphate complexes against Mycobacterium tuberculosis
Greenfield, Tiffany
Doyle, Robert
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
[8] Structure-activity relationships of 2-aminothiazoles effective against Mycobacterium tuberculosis
Meissner, Anja
Boshoff, Helena I.
Vasan, Mahalakshmi
Duckworth, Benjamin P.
Barry, Clifton E., III
Aldrich, Courtney C.
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (21) : 6385 - 6397
[9] Structure-Activity relationship in mutated pyrazinamidases from Mycobacterium tuberculosis
Quiliano, Miguel
Hazaet Gutierrez, Andres
Hugh Gilman, Robert
Lopez, Cesar
Evangelista, Wilfredo
Sotelo, Jun
Sheen, Patricia
Zimic, Mirko
BIOINFORMATION, 2011, 6 (09) : 335 - 339
[10] Structure-Activity Relationships of Wollamide Cyclic Hexapeptides with Activity against Drug-Resistant and Intracellular Mycobacterium tuberculosis
Khalil, Zeinab G.
Hill, Timothy A.
Rodriguez, Luis M. De Leon
Lohman, Rink-Jan
Hoang, Huy N.
Reiling, Norbert
Hillemann, Doris
Brimble, Margaret A.
Fairlie, David P.
Blumenthal, Antje
Capon, Robert J.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)

← 1 2 3 4 5 →